Considering a move to #IQVIA, but your dream job isn't available yet? ✍🏽 Join our Global Talent Network and we'll let you know when it is! https://bit.ly/4d4FeZd#WeAreIQVIA
Do you need help balancing new product development to drive growth while managing regulatory compliance of mature products?
Are you looking for a cost-effective and flexible solution that combines 3,300+ global regulatory experts with AI/ML technology?
IQVIA’s Lifecycle Management (LCM) Services blends human expertise, technological flexibility, and strategic insights to offer a comprehensive suite of solutions tailored for seamless navigation and adaptability in evolving regulatory landscapes.
Discover how IQVIA’s LCM services created a 30% cost-saving for a pharma customer: https://bit.ly/3LnLGhL#LifecycleMaintenance#RegulatoryLabeling#RegulatoryOperations
Check out this newly published report featuring a Clinical Trial Readiness Analysis developed by the IQVIA Institute that allows for ranking of countries by trial type, and surfaces near- and long-term opportunities for investment and improvement in country utilization.
🔍 New report out now: Rethinking Clinical Trial Country Prioritization
The biopharma clinical research ecosystem has undergone significant evolution over the past five years due to technological, environmental, societal, regulatory, and geopolitical shifts. These changes have reshaped clinical trial activities and operations, bringing both opportunities and challenges.
📊 Our latest report explores:
✅ The emergence of new global players in clinical trials.
✅ Execution challenges, delays, capacity concerns, and uncertainties impacting clinical development timelines and patient outcomes.
✅ The critical focus on global diversification of clinical trials.
✅ Trends in enrollment timelines, trial characteristics, and country utilization.
✅ Exploration of countries with high patient recruitment potential.
Get your copy of the report: https://lnkd.in/erWtB-qG#ClinicalTrials#GlobalHealth#HealthEquity
IQVIA Transparency Reporting is helping LEO Pharma, a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, keep up with consistently changing global transparency legislations, regulations, and codes, which is a major challenge for life sciences companies of all sizes. IQVIA’s Transparency Reporting makes reporting seamless with a user-friendly, intuitive process, and best-in-class SaaS technology, combined with continuous legal monitoring expertise that provides regulatory updates to stay compliant.
“LEO Pharma utilizes IQVIA's Transparency Reporting solution to streamline our global transparency reporting process, significantly reducing the time and resources previously devoted to the reporting process. The advanced analytics and user-friendly dashboards have empowered us to focus more on strategic growth while ensuring compliance with changing global regulations.” said the Head of HCP Compliance at LEO Pharma.
LEO Pharma uses IQVIA’s Transparency Reporting solution to meet global transparency requirements across 22 countries. With this robust SaaS solution, the company can streamline their data integration from all sources, remediate and manage spend with in depth reporting tools, and utilize robust analytics to drive greater compliance insights, all on a single platform.
For more information on IQVIA Transparency Reporting, visit https://bit.ly/4bLMCY1.
Are you planning for evidence generation and dissemination early enough in your product’s lifecycle? Partner with IQVIA Medical Affairs to advance healthcare decision-making that improves patient outcomes.
https://bit.ly/3zEQj4z#medaffairs
We are excited to announce that Everest Group has recognized IQVIA as a Leader in Life Sciences Regulatory and Medical Affairs Operations. #IQVIANewsroom
“IQVIA is honored to be recognized for its role in enabling our medical affairs and regulatory customers to close the gap between medical knowledge and medical practice to improve patients’ lives” said Rob Kotchie, president, Real World Solutions, IQVIA.
Read the full press release here: https://bit.ly/3WhxpcM
Let your true potential shine during the interview process. See our list of tips for before, during and after your IQVIA interview: https://bit.ly/3zEdc8p#GetHired#WeAreIQVIA
This article by IQVIA’s Mackenzie Herzog and fellow sports medicine experts, Andrew Kuhn, M.D., Nate Weir, MS, LAT, ATC, and Bob Anderson, correlates EMR data on ankle injuries in #NFL athletes with advanced imaging findings to understand how diagnosis impacts time to return to full participation. Learn how an evidence hub of linked and integrated health and statistical data sources can provide a foundation for decision-making and inform strategies for injury management.
https://bit.ly/4cWg2nk
Our five-step #onboarding experience not only sets new employees up to do extraordinary things for our customers and partners, but helps them feel inspired, connected and enabled to do great things here. Learn more about our onboarding program: https://bit.ly/3xDlzAw#WeAreIQVIA
GVHD after HSCT is associated with poor HRQoL and functional status. This analysis, co-authored by IQVIA’s James Turnbull, assessed physical, cognitive, and work disability, and described factors predictive of disability in patients with chronic GVHD. The results highlight a need for improved social support for these patients. https://bit.ly/3Lj37jy
Chief Executive Officer at USA and International Research Inc.
1wGreat initiative! Signed up for the Global Talent Network—looking forward to hearing about future opportunities at #IQVIA!